Boardroom chatter
Anatomy of an Outlicensing Deal
A MotionHall Whitepaper

For individuals that are either new to the pharmaceutical industry or the disciplines of biopharma dealmaking, the process of how a licensing deal emerges and subsequently gets signed might not be that obvious. The licensing process can be lengthy and sometimes very mysterious.

Often due to the stock sensitive and confidential nature of a deal, the measures that business development executives are taking to get a deal done are not transparent. To help understand the underlying anatomy of an out-licensing deal process, we’ve uncovered and identified 15 fundamental steps associated with successful biopharma deals.

Sign-up below to gain access to the full report (PDF):